Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Buggia

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Pharmacokinetics|February 1, 1996
Clinically significant drug interactions with cyclosporin. An updateC Campana, M B Regazzi, I Buggia, et al.
The Annals of Pharmacotherapy|September 1, 1994
BusulfanI Buggia, F Locatelli, M B Regazzi, et al.
Thrombosis and Haemostasis|August 1, 1997
Nitrite and nitrate plasma levels, as markers of nitric oxide synthesis, in antiphospholipid antibodies-related conditions and in thrombotic thrombocytopenic purpuraC Porta, I Buggia, I Bonomi, et al.
Bollettino Chimico Farmaceutico|November 1, 1992
[The bioavailability of nicorandil after oral administration of a single dose of 10 or 20 mg preparations]M Molinaro, P Villani, I Buggia, et al.
Therapeutic Drug Monitoring|April 1, 1994
High-performance liquid chromatography determination of pravastatin in plasmaI Iacona, M B Regazzi, I Buggia, et al.
Clinical Pharmacology and Therapeutics|July 1, 1993
Disposition of high-dose busulfan in pediatric patients undergoing bone marrow transplantationM B Regazzi, F Locatelli, I Buggia, et al.
Journal of Clinical Pharmacy and Therapeutics|April 1, 1994
Evaluation of two buflomedil tablet formulations in patients with atherosclerotic diseaseM Molinaro, M B Regazzi, S Raffaghello, et al.
European Journal of Clinical Investigation|March 27, 1999
The effects of iloprost infusion on microcirculation is independent of nitric oxide metabolites and endothelin-1 in chronic peripheral ischaemiaA Mazzone, C Cusa, L Bucci, et al.
Anticancer Research|July 1, 1996
Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo)I Buggia, M Zecca, E P Alessandrino, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Pharmacokinetics|February 1, 1996
Clinically significant drug interactions with cyclosporin. An updateC Campana, M B Regazzi, I Buggia, et al.
The Annals of Pharmacotherapy|September 1, 1994
BusulfanI Buggia, F Locatelli, M B Regazzi, et al.
Thrombosis and Haemostasis|August 1, 1997
Nitrite and nitrate plasma levels, as markers of nitric oxide synthesis, in antiphospholipid antibodies-related conditions and in thrombotic thrombocytopenic purpuraC Porta, I Buggia, I Bonomi, et al.
Bollettino Chimico Farmaceutico|November 1, 1992
[The bioavailability of nicorandil after oral administration of a single dose of 10 or 20 mg preparations]M Molinaro, P Villani, I Buggia, et al.
Therapeutic Drug Monitoring|April 1, 1994
High-performance liquid chromatography determination of pravastatin in plasmaI Iacona, M B Regazzi, I Buggia, et al.
Clinical Pharmacology and Therapeutics|July 1, 1993
Disposition of high-dose busulfan in pediatric patients undergoing bone marrow transplantationM B Regazzi, F Locatelli, I Buggia, et al.
Journal of Clinical Pharmacy and Therapeutics|April 1, 1994
Evaluation of two buflomedil tablet formulations in patients with atherosclerotic diseaseM Molinaro, M B Regazzi, S Raffaghello, et al.
European Journal of Clinical Investigation|March 27, 1999
The effects of iloprost infusion on microcirculation is independent of nitric oxide metabolites and endothelin-1 in chronic peripheral ischaemiaA Mazzone, C Cusa, L Bucci, et al.
Anticancer Research|July 1, 1996
Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo)I Buggia, M Zecca, E P Alessandrino, et al.
Pageof 1